SEC Form 4
Impact BioMedical, Inc. (IBO) insider trading
In the 12 months to Oct 26, 2026, 3 IBO insiders reported open-market sales of $147.5K across 4 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $147.5K
- 4 filings · 3 insiders
- Open-market purchases
- $0
- 0 filings
Who traded IBO, and when
- Sale
IBO daily close from Oct 27, 2025 to Oct 26, 2026, between $2.68 and $9.84, last $3.47. 4 sale and 0 purchase filings by 3 insiders, marked at their filing dates. DSS, INC., 10% owner: sold $89.7K across 2 filings, first filed Jan 6, 2026, last Sep 24, 2026. Jason Grady, Director: sold $32.5K across 1 filing, first filed Mar 25, 2026, last Mar 25, 2026. Todd D. Macko, Chief Financial Officer: sold $25.3K across 1 filing, first filed Mar 30, 2026, last Mar 30, 2026.
Largest mark · tap a row for others
DSS, INC. · 10% owner
Sale $88,006
161,000 shares at $0.55 avg
Filed Jan 6, 2026 · traded May 22
Close on filing date $6.69
DSS, INC. · 10% owner
10% owner
$89.7K soldJason Grady · Director
Director
$32.5K soldTodd D. Macko · Chief Financial Officer
Chief Financial Officer
$25.3K soldOpen-market trades
4 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| DSS, INC. | 10% owner | $89.7K | — | 2 | — | |
| Jason Grady | Director | $32.5K | — | 1 | — | |
| Todd D. Macko | Chief Financial Officer | $25.3K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | DSS, INC. 10% owner | Sale | 906 | $1.86 | $1.7K | 589,518 | |
traded | Todd D. Macko Chief Financial Officer | Sale | 45,000 | $0.56 | $25.3K | 155,122 | |
traded | Jason Grady Director | Sale | 50,000 | $0.65 | $32.5K | 250,182 | |
traded | DSS, INC. 10% owner | Sale | 161,000 | $0.55 | $88.0K | 545,024 |
GET /stocks/filings/vX/form-4?tickers=IBO&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"IBO"
],
"issuer_cik": "0001834105",
"owner_cik": "0000771999",
"accession_number": "0001493152-26-044207",
"form_type": "4",
"filing_date": "2026-09-24",
"period_of_report": "2026-09-22",
"issuer_name": "IMPACT BIOMEDICAL INC.",
"issuer_trading_symbol": "IBO",
"owner_name": "DSS, INC.",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-23",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 27,
"transaction_price_per_share": 6.95,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 589674,
"transaction_value": 187.65,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"remarks": "This entity is a wholly-owned subsidiary of DSS, Inc."
},
{
"tickers": [
"IBO"
],
"issuer_cik": "0001834105",
"owner_cik": "0000771999",
"accession_number": "0001493152-26-044207",
"form_type": "4",
"filing_date": "2026-09-24",
"period_of_report": "2026-09-22",
"issuer_name": "IMPACT BIOMEDICAL INC.",
"issuer_trading_symbol": "IBO",
"owner_name": "DSS, INC.",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-24",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 156,
"transaction_price_per_share": 7.0587,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 589518,
"transaction_value": 1101.1572,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"remarks": "This entity is a wholly-owned subsidiary of DSS, Inc."
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
How current is IBO’s insider data?
These are IBO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track IBO insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for IBO every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.